Literature DB >> 21822622

Braking self-cannibalism in cancer.

Friedrich C Luft1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21822622     DOI： 10.1007/s00109-011-0791-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  8 in total

1.  Case records of the Massachusetts General Hospital. Case 11-2011. A 47-year-old man with systemic lupus erythematosus and heart failure.

Authors:  Christopher Newton-Cheh; Angela E Lin; Aaron L Baggish; He Wang
Journal:  N Engl J Med       Date:  2011-04-14       Impact factor: 91.245

2.  Autophagy suppression promotes apoptotic cell death in response to inhibition of the PI3K-mTOR pathway in pancreatic adenocarcinoma.

Authors:  Olga K Mirzoeva; Byron Hann; Yun K Hom; Jayanta Debnath; Dana Aftab; Kevan Shokat; W Michael Korn
Journal:  J Mol Med (Berl)       Date:  2011-06-16       Impact factor: 4.599

Review 3.  Core signaling pathways of survival/death in autophagy-related cancer networks.

Authors:  Shu-ya Wang; Qi-jia Yu; Ru-dian Zhang; Bo Liu
Journal:  Int J Biochem Cell Biol       Date:  2011-05-26       Impact factor: 5.085

4.  Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis.

Authors:  Jessie Yanxiang Guo; Hsin-Yi Chen; Robin Mathew; Jing Fan; Anne M Strohecker; Gizem Karsli-Uzunbas; Jurre J Kamphorst; Guanghua Chen; Johanna M S Lemons; Vassiliki Karantza; Hilary A Coller; Robert S Dipaola; Celine Gelinas; Joshua D Rabinowitz; Eileen White
Journal:  Genes Dev       Date:  2011-02-11       Impact factor: 11.361

Review 5.  Autophagy as a target for anticancer therapy.

Authors:  Filip Janku; David J McConkey; David S Hong; Razelle Kurzrock
Journal:  Nat Rev Clin Oncol       Date:  2011-05-17       Impact factor: 66.675

6.  Pancreatic cancers require autophagy for tumor growth.

Authors:  Shenghong Yang; Xiaoxu Wang; Gianmarco Contino; Marc Liesa; Ergun Sahin; Haoqiang Ying; Alexandra Bause; Yinghua Li; Jayne M Stommel; Giacomo Dell'antonio; Josef Mautner; Giovanni Tonon; Marcia Haigis; Orian S Shirihai; Claudio Doglioni; Nabeel Bardeesy; Alec C Kimmelman
Journal:  Genes Dev       Date:  2011-03-15       Impact factor: 11.361

7.  PIK3CA and KRAS mutations predict for response to everolimus therapy: now that's RAD001.

Authors:  Morassa Mohseni; Ben Ho Park
Journal:  J Clin Invest       Date:  2010-07-26       Impact factor: 14.808

8.  Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus.

Authors:  Federica Di Nicolantonio; Sabrina Arena; Josep Tabernero; Stefano Grosso; Francesca Molinari; Teresa Macarulla; Mariangela Russo; Carlotta Cancelliere; Davide Zecchin; Luca Mazzucchelli; Takehiko Sasazuki; Senji Shirasawa; Massimo Geuna; Milo Frattini; José Baselga; Margherita Gallicchio; Stefano Biffo; Alberto Bardelli
Journal:  J Clin Invest       Date:  2010-07-26       Impact factor: 14.808
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.